Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2013		Mar. 31, 2012
Operating activities:
Net (loss) income	$ (1,225,669)	[1]	$ 11,045
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization	239,577
Interest expense	236,996		264
Changes in assets and liabilities:
Accounts receivable	41,579		16,062
Inventory	205,040
Prepaid expenses and other	(63,093)		113
Accounts payable and accrued expenses	88,934		(3,595)
Accounts payable-related party	(158,729)
Deferred revenue	(169,826)		(21,670)
Net cash (used in) provided by operating activities	(805,191)		2,219
Investing Activities:
Cash acquired in acquisition	84,062
Financing activities:
Line of credit, net change	421,299		(486)
Repayments on long-term debt	(31,374)
Net cash used in financing activities	389,925		(486)
Increase (decrease) in cash	(331,204)		1,733
Cash and cash equivalents at beginning of year	19,032,392		10,766
Cash and cash equivalents at end of year	18,701,188		12,499
Non-cash transactions:
Convertible note issued related to acquisition	6,500,000
Promissory note issued related to acquisition	$ 4,000,000

[1] Includes a full quarter of CVSL and HCG but only 13 days of results for TLC. Please see footnote (2).